Providing for consideration of the bill (H.R. 3617) to decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; providing for consideration of the bill (H.R. 6833) to amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes; and for other purposes.

Bill 117 hres 1017, also known as the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, is a piece of legislation that aims to decriminalize and deschedule cannabis at the federal level. The bill also seeks to reinvest in individuals who have been adversely impacted by the War on Drugs, particularly communities of color that have been disproportionately affected by harsh drug laws.

Additionally, the MORE Act includes provisions for expungement of certain cannabis offenses, allowing individuals with past convictions related to marijuana to have their records cleared. This is seen as a way to provide these individuals with a fresh start and remove barriers to employment, housing, and other opportunities.

In addition to the cannabis-related provisions, Bill 117 hres 1017 also addresses the issue of insulin affordability. The bill includes measures to establish requirements for cost-sharing for certain insulin products, with the goal of making this life-saving medication more accessible and affordable for those who need it. Overall, the MORE Act is a comprehensive piece of legislation that addresses both criminal justice reform and healthcare affordability. It aims to address longstanding issues related to drug policy and healthcare access, with the goal of creating a more just and equitable society for all Americans.